Malignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritis.
Department of Rheumatology, Copenhagen University Hospital Gentofte, Hellerup, Denmark.
René
R
Cordtz
Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Lene
L
Mellemkjær
Department of Rheumatology, Copenhagen University Hospital Gentofte, Hellerup, Denmark.
Bente
B
Glintborg
DANBIO Registry and Center for Rheumatology and Spine Diseases, Glostrup Hospital, Glostrup, Denmark Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Denmark.
Merete Lund
ML
Hetland
Department of Rheumatology, Copenhagen University Hospital Gentofte, Hellerup, Denmark.
Lene
L
Dreyer
D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy* / Q000453:epidemiology; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D002584:Cervix Uteri / Q000473:pathology* / Q000821:virology; D015897:Comorbidity; D003718:Denmark / Q000453:epidemiology; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000150:complications / Q000453:epidemiology; D011230:Precancerous Conditions / Q000453:epidemiology*; D012042:Registries; D012189:Retrospective Studies; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000821:virology
D018501:Antirheumatic Agents
DMARDs (biologic); DMARDs (synthetic); Epidemiology; Infections; Rheumatoid Arthritis